T1	Participants 102 138	patients with advanced solid tumours
T2	Participants 503 539	Patients with advanced solid tumours
T3	Participants 852 886	Twenty-seven patients were treated
T4	Participants 1245 1311	Four patients achieved partial responses and 17 had stable disease
T5	Participants 1313 1345	lasting >3 months in 14 patients
